Skip to main content

Table 2 Clinicopathologic features of patients with normal mucosa or PanIN-1 and those with PanIN-2 or PanIN-3 at the PTM

From: Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma

Parameters

Normal mucosa and PanIN-1 (n = 57)

PanIN-2 and PanIN-3 (n = 21)

P value

Median age (range)

69 (45–85)

69 (56–90)

0.257

Sex

 Male

31

7

0.128

 Female

26

14

Tumor location

 Head

33

15

0.308

 Body and tail

24

6

Differentiation grade of PDAC

 G1/G2

50

19

1.000

 G3/G4

7

2

Differentiation grade of PDAC

 G1

26

11

0.619

 G2/G3/G4

31

10

TNM stage

 I/II

49

18

1.000

 III/IV

8

3

Tumor size

 pT1/pT2

50

20

0.437

 pT3/pT4

7

1

Microvascular invasion

 Positive

52

18

0.383

 Negative

4

3

 Unknown

1

  

Lymphatic permeation

 Positive

39

15

1.000

 Negative

18

6

Perineural invasion

 Positive

47

15

0.346

 Negative

10

6

Nodal metastasis

 pN0

22

9

0.797

 pN1/pN2

35

12

Neoadjuvant chemotherapy

 Yes

36

9

0.127

 No

21

12

Adjuvant chemotherapy

 Yes

50

19

1.000

 No

5

1

 Unknown

2

1

 

Postoperative radiotherapy

 Yes

2

2

0.292

 No

55

19

  1. Patients with invasive cancer at any resection margins other than the PTM are excluded. PanIN pancreatic intraepithelial neoplasia, PTM pancreatic transection margin, PDAC pancreatic ductal adenocarcinoma, G1 well-differentiated carcinoma, G2 moderately differentiated carcinoma, G3 poorly differentiated carcinoma, G4 undifferentiated carcinoma